Cytosorbents Corporation (NASDAQ:CTSO) tinted loss of -1.21% (-0.15 points) to US$12.2. The volume of 0.18 Million shares climbed down over an trading activity of 333.86 Million shares. EPS ratio determined by looking at last 12 month figures is -0.35. Over the same time span, the stock marked US$12.5 as its best level and the lowest price reached was US$4.25. The corporation has a market cap of US$368.07 Million.

Cytosorbents Corporation (NASDAQ:CTSO)’s earnings per share has been growing at a 16.4 percent rate over the past 5 year when average revenue increase was noted as 62.4 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -45.2 percent. The company’s institutional ownership is monitored at 13.4 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 65.6 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 2. 4 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

The India Fund, Inc. (NYSE:IFN) is worth US$673.2 Million and has recently fallen -1.21% to US$24.4. The latest exchange of 0.06 Million shares is below its average trading activity of 72.61 Million shares. The day began at US$24.55 but the price moved to US$24.39 at one point during the trading and finally capitulating to a session high of US$24.62. The stock tapped a 52-week high of US$28.32 while the mean 12-month price target for the shares is US$0.

Currently, the stock carries a price to earnings ratio of 2.89, a price to book ratio of 0.81, and a price to sales ratio of 65.36. For the past 5 years, the company’s revenue has grown -7.8%, while the company’s earnings per share has grown 11.4%. With an institutional ownership near 33.1%, it carries an earnings per share ratio of 8.43.